Study Hypothesis: Safety and Tolerability will differ when treating multiple contiguous 25 cm2 treatment areas, as compared to individual 25 cm2 treatment areas.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
64
0.05%, two day dose
Radiant Research
Tucson, Arizona, United States
Skin Surgery Medical Group Inc.
San Diego, California, United States
Park Avenue Dermatology
Orange Park, Florida, United States
Safety and tolerability (incidence of AEs, SAEs and skin responses)
Time frame: Screening to End of Study (Day 57)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Advanced Dermatology and Cosmetic Surgery
Ormond Beach, Florida, United States
Radiant Research Inc.
Pinellas Park, Florida, United States
Medaphase Inc
Newnan, Georgia, United States
Karen S. Harkaway, MD LLC
Riverside Park, New Jersey, United States
J&S Studies
College Station, Texas, United States
St George Dematology and Skin and Cancer Centre
Kogarah, Sydney, New South Wales, Australia
South East Dermatology, Belmont Specialist Centre
Carina Heights, Brisbane, Queensland, Australia
...and 3 more locations